Liang C, Zhang X, Yang M, Dong X
White analytical insight for sensitive fluorescent determination of semaglutide and tirzepatide in pharmaceuticals and biological matrices
The IRS treats prescribed compounded medicines as Section 213(d) qualified expenses when they are medical care, but some HRA plans now explicitly exclude compounded GLP-1s, and FSA and HSA administrators may require additional substantiation
The following interactions are largely theoretical or based on case reports, but warrant clinical caution: Insulin and oral hypoglycaemic agents (e.g., sulfonylureas) there is a theoretical risk of enhanced blood glucose-lowering effects, potentially contributing to hypoglycaemia Diuretics concurrent use may exacerbate potassium depletion (hypokalaemia) Digoxin low potassium levels can increase the risk of digoxin toxicity Long-term or high-dose consumption of acetic acid has been associated with reduced bone mineral density and low potassium levels in published case reports, though evidence from pill-based supplementation specifically is sparse
Detailed PK/ADME data for BPC-157 in any species are limited
WOSINSKA: But then what happened is once FDA announced the shortage, you see the floodgates open